Sphingolipid Metabolism: Sphingoid Analogs, Sphingolipid Activator Proteins, and the Pathology of the Cella
- 1 June 1998
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 845 (1) , 139-151
- https://doi.org/10.1111/j.1749-6632.1998.tb09667.x
Abstract
Sphingolipid metabolism and function was investigated using sphingoid analogs, cells from human sphingolipidoses patients, and knockout animals. Treatment of primary cultured murine cerebellar cells with the structurally modified sphingosine base cis‐4‐methylsphingosine resulted in decreased sphingolipid biosynthesis accompanied by significant morphological changes. Plasma‐membrane‐derived glycosphingolipids (GSLs) destined for digestion are internalized through the endocytic pathway and delivered to lysosomes. There, GSLs are degraded by the action of exohydrolases, which are supported, in the case of GSLs with short oligosaccharide chains, by sphingolipid activator proteins (SAPs or saposins). The inherited deficiency of activators give rise to sphingolipid storage diseases. The analysis of cultured fibroblasts from corresponding patients suggests a new model for the topology of endocytosis and lysosomal digestion. Mice with disrupted genes for activator proteins and for GM2 degrading hexosaminidases turned out to be useful models for human diseases.Keywords
This publication has 50 references indexed in Scilit:
- Gangliosides -- A new therapeutic agent against stroke and Alzheimer's diseaseLife Sciences, 1994
- Biosynthesis of sphingolipids: Dihydroceramide and not sphinganine is desaturated by cultured cellsBiochemical and Biophysical Research Communications, 1992
- Activator proteins and topology of lysosomal sphingolipid catabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- A mutation in the gene of a glycolipid‐binding protein (GM2 activator) that causes GM2‐gangliosidosis variant ABFEBS Letters, 1991
- Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher diseaseFEBS Letters, 1991
- Sphingolipid biosynthesis in cultured neuronsEuropean Journal of Biochemistry, 1991
- Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosesEuropean Journal of Pediatrics, 1989
- ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIAAnnual Review of Biochemistry, 1989
- The Precursor of Sulfatide Activator Protein is Processed to Three Different ProteinsBiological Chemistry Hoppe-Seyler, 1988
- Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986